Announced Thu, 4 Jun · 18:26 IST

Intimation regarding Non-Approval of Audited Financial Results for the Quarter and Year Ended March 31, 2026

GENCON · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.0%1-day move
₹39.99
prior close
₹40.30
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.3-1.2-1.6-2.0-2.0-1.4-0.8-7.5-3.1-4.8+10.2+8.5
Up moveDown movePending
AI summary

The company informed BSE and NSE that its Board of Directors, at the meeting held on May 29, 2026, could not consider and approve the Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2026. The company stated that another Board Meeting will be convened at the earliest to consider and approve these results, with the date to be communicated separately. The trading window for designated persons and their immediate relatives remains closed until 48 hours after the declaration of the audited results.

Likely market impact

The delay in approving audited annual results is a negative signal for shareholders, as it creates uncertainty and may raise concerns about the company's financial position or reporting quality. Investors should watch for the next board meeting announcement and any subsequent disclosures for clarity on the reasons behind the delay.